Cargando…

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

BACKGROUND: In pT1-T3N0 urothelial carcinoma of the bladder (UCB) patients, multi-modal therapy is inconsistently recommended. The aim of the study was to develop a prognostic tool to help decision-making regarding adjuvant therapy. METHODS: We included 2145 patients with pT1-3N0 UCB after radical c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xylinas, E, Cha, E K, Sun, M, Rink, M, Trinh, Q-D, Novara, G, Green, D A, Pycha, A, Fradet, Y, Daneshmand, S, Svatek, R S, Fritsche, H-M, Kassouf, W, Scherr, D S, Faison, T, Crivelli, J J, Tagawa, S T, Zerbib, M, Karakiewicz, P I, Shariat, S F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504939/ https://www.ncbi.nlm.nih.gov/pubmed/23169335 http://dx.doi.org/10.1038/bjc.2012.464

Ejemplares similares

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
por: Xylinas, E, et al.
Publicado: (2013)

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes
por: Moschini, Marco, et al.
Publicado: (2019)

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
por: Moschini, Marco, et al.
Publicado: (2017)

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study
por: Passoni, Niccolò M., et al.
Publicado: (2016)

Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges—a narrative review
por: von Deimling, Markus, et al.
Publicado: (2022)

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer
por: Mayr, Roman, et al.
Publicado: (2018)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
por: Monteiro, Leonardo L., et al.
Publicado: (2017)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Diffusion of robot-assisted radical cystectomy: Nationwide trends, predictors, and association with continent urinary diversion
por: Elshabrawy, Ahmed, et al.
Publicado: (2022)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020)

Is ovarian reserve reduction following endometriotic cystectomy predicted? The implication for fertility preservation counseling
por: Younis, Johnny S., et al.
Publicado: (2022)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy
por: Yu, Alice, et al.
Publicado: (2018)

Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
por: D’Andrea, David, et al.
Publicado: (2019)

Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada
por: Wissing, Michel D., et al.
Publicado: (2023)

Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review
por: König, Frederik, et al.
Publicado: (2022)

Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada
por: Santos, Fabiano, et al.
Publicado: (2015)

The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol
por: Zainfeld, Daniel, et al.
Publicado: (2018)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

The current role of precision surgery in oligometastatic prostate cancer
por: von Deimling, M., et al.
Publicado: (2022)

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit
por: Tan, Wei Shen, et al.
Publicado: (2021)

Impact of Patient, Surgical, and Perioperative Factors on Discharge Disposition after Radical Cystectomy
por: Cacciamani, Giovanni E., et al.
Publicado: (2022)

Patterns of recurrence of bladder carcinoma following radical cystectomy
por: Koh, D. M., et al.
Publicado: (2015)

The association between sarcopenia and bladder cancer-specific mortality and all-cause mortality after radical cystectomy: A systematic review and meta-analysis
por: Ibilibor, Christine, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy
por: Zattoni, Fabio, et al.
Publicado: (2023)

The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2023)

Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group
por: Marcq, Gautier, et al.
Publicado: (2022)

Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Α high-volume single center study
por: Stamatakos, Panagiotis Velissarios, et al.
Publicado: (2022)

Online tools for patient counseling in bladder and kidney cancer—ready for prime time?
por: Gild, Philipp, et al.
Publicado: (2017)

Incidence and preoperative predictors for major complications following radical nephroureterectomy
por: Kocher, Neil J., et al.
Publicado: (2020)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
por: Nguyen, Thanh-Tuan, et al.
Publicado: (2018)

Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer
por: von Deimling, Markus, et al.
Publicado: (2023)

Optimal timing of chemotherapy and cystectomy
por: Karam, Jose A, et al.
Publicado: (2010)

Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center
por: Sobhani, Sina, et al.
Publicado: (2023)

Laparoscopic Large Dermoid Cystectomy in Pregnancy
por: Atileh, Luay Ibrahim Abu, et al.
Publicado: (2023)

Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy
por: Vartolomei, Mihai Dorin, et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery
por: Pallauf, Maximilian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4ucbk8v0mv69sklk30bu8larb